stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G - Contineum Therapeutics, Inc. Class A Common Stock | StockGist | StockGist
Companies
CTNM
SCHEDULE 13G
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
CTNM
SCHEDULE 13G
SCHEDULE 13G
Beneficial Ownership
Contineum Therapeutics, Inc. Class A Common Stock
Filed Feb 17, 2026
Accepted Feb 16, 2026, 7:00 PM ET
CTNM
CIK 0001855175
View on SEC.gov
Company Profile
0001193125-26-052863
Beneficial Ownership Report
Passive Investment
Shares Owned
2,312,800
Reporting Person
Contineum Therapeutics, Inc.
Person Type
IA
CUSIP: 21217B100
Amendment History
3 filings
SCHEDULE 13G
Original
Viewing
Feb 17, 2026
0001193125-26-052863
SCHEDULE 13G/A
Amendment 1
Jan 29, 2026
0000038777-26-000010
SCHEDULE 13G/A
Amendment 2
Latest
Feb 17, 2026
0001346824-26-000037